Suitability of Japanese Medical Databases for Studies on Infant Outcomes After Maternal Drug Exposure: An Evaluation Based on Core Data Elements
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Shiro Hatakeyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Databases, Factual, Pharmacoepidemiology, Drug-Related Side Effects and Adverse Reactions, Maternal Exposure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kakenhi, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Purpose
Pharmacotherapy during pregnancy should be approached with caution due to the potential risk of adverse effects, including birth defects, in the fetus. Appropriate post‐marketing surveillance and perinatal pharmacoepidemiology are essential to ensure the safety of pharmacotherapy during pregnancy. However, due to limited research infrastructure in pharmacoepidemiology, collecting reliable data on drug safety in pregnant women and infants remains a challenge in Japan. Thus, we examined the suitability (fitness for purpose) of Japanese medical databases for perinatal studies to establish infrastructure in this field.
Methods
We assessed seven available databases in Japan: the DeSC database, EBM provider, Japanese Adverse Drug Event Report database, JMDC claims database, MDV analyzer, the National Database of Health Insurance Claims, and Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study (TMM BirThree Cohort Study). To assess the quality of databases for maternal studies, we evaluated the content of each mother‐infant linkable database based on the core data elements recommended for perinatal pharmacoepidemiology.
Results
Three of the databases were found to be mother‐infant linkable: the DeSC database, JMDC claims database, and the TMM BirThree Cohort Study. The coverage of core data elements in perinatal pharmacoepidemiology was 73.5% in the DeSC and JMDC claims databases and 92.9% in the TMM BirThree Cohort Study.
Conclusion
Some representative medical databases in Japan are well suited for use in perinatal pharmacoepidemiologic research on infant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan.
- Department of Pharmacy, Yamagata University Hospital, Yamagata, Japan.
- Drug Informatics, Faculty of Pharmacy, Meijo University, Nagoya, Aichi, Japan.
- Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
- Division of Community Medicine and Pharmacy, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
- KTS Plan Inc., Sendai, Miyagi, Japan.
ORCID-Profile: Shiro Hatakeyama, Takamasa Sakai, Masami Tsuchiya, Yuki Kondo, Izumi Sato
Förderung
- Kakenhi
- Japan Society for the Promotion of Science
Zitieren
APA
Hatakeyama, S., Sakai, T., Tsuchiya, M., Kikuchi, D., Sato, Y., Kondo, Y., Sato, I., Okada, Y., & Obara, T. (2025). Suitability of Japanese Medical Databases for Studies on Infant Outcomes After Maternal Drug Exposure: An Evaluation Based on Core Data Elements. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70264
Vancouver
Hatakeyama S, Sakai T, Tsuchiya M, Kikuchi D, Sato Y, Kondo Y, et al. Suitability of Japanese Medical Databases for Studies on Infant Outcomes After Maternal Drug Exposure: An Evaluation Based on Core Data Elements. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70264
BibTeX
@article{Hatakeyama2025,
author = {Hatakeyama, Shiro and Sakai, Takamasa and Tsuchiya, Masami and Kikuchi, Daisuke and Sato, Yuri and Kondo, Yuki and Sato, Izumi and Okada, Yuko and Obara, Taku},
title = {Suitability of Japanese Medical Databases for Studies on Infant Outcomes After Maternal Drug Exposure: An Evaluation Based on Core Data Elements},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70264}
}
EUVIMED